Background: Children are categorized as short stature when the Height for Age results are below the 3rd percentile of CDC growth chart standard. Short stature on children will have an impact on increased mortality and morbidity, children's cognitive development, and psychological abilities. This study aims to investigate the effect of short stature on cognitive abilities and psychosocial condition of primary school children. Subjects and Method:A cross-sectional study was conducted at Pasar Kliwon 01 Primary School, Surakarta, Central Java, Indonesia. A total of 81 students from 3rd -5th grades of were selected by consecutive sampling. The dependent variables were cognitive ability and psychosocial condition. The independent variable was body height. Body height was measured by microtoise. Cognitive ability was assessed based on mathematics, Indonesian language, and natural sciences score. Psycho-social condition was assessed using Pediatric Symptom Checklist-17. The data were analyzed by a multiple logistic regression. Results: Short stature increased cognitive ability (OR= 2.86; 95% CI= 1.03 to 7.92; p= 0.043), and it was statistically significant. Short stature increased psychosocial condition, (OR= 2.24; 95% CI= 0.51 to 9.70; p= 0.279), but it was statistically non-significant. Conclusion: Short stature increases cognitive ability and psychosocial condition.
Results. From 359 children with dengue infection, there were 41 patients suffered from dengue fever, 306 patients suffered from dengue hemorrhagic fever, and 12 patient suffered from dengue shock syndrome. 182 patients were boys and 177 patients were girls. 132 patients were 0-5 years old group and 227 patients were >5-18 years old group. Ninety cases were happened in dry season and 269 cases were happened in rainy season. All cases showed positive NS1. Conclusion. From 359 subject, the most case is dengue hemorrhagic fever , that happened in boys with the most common age group is >5-18 years old, and in rainy season. Sari Pediatri 2016;17(5):379-83.
Latar belakang. Kemoterapi pada leukemia limfoblastik akut (LLA) memiliki berbagai efek samping. Toksisitas dapat menyebabkan penundaan kemoterapi dan mempengaruhi hasil pengobatan. pada negara maju kesintasan pasien LLA cukup baik namun berbeda di negara berkembang. Tujuan. membuktikan apakah toksisitas kemoterapi hematologi fase konsolidasi mempengaruhi kesintasan pasien LLA anak. Metode. Pasien berusia 1 bulan – 18 tahun yang terdiagnosis LLA dan telah menjalani kemoterapi fase konsolidasi di RSUD Dr. Moewardi Surakarta pada periode bulan Januari 2017 – September 2019 diikutkan dalam penelitian. Data rekam medis tidak lengkap dan pasien down sindrom dieksklusi. Toksisitas kemoterapi hematologi fase konsolidasi dinilai pada setiap subjek berdasarkan kriteria NCI-CTCAE. Kesintasan dan Hazard rasio diperkirakan menggunakan metode Kaplan-Meier dan cox regression. Analisis multivariat regresi cox model interaksi digunakan untuk menganalisa faktor yang paling menentukan kesintasan.Hasil. Sejumlah 46 subjek diikutsertakan dalam penelitian. Toksisitas derajat ringan-sedang (derajat 1-2) sebanyak 34 (73,9%) derajat berat (derajat 3-4) sebanyak 12 (25,6%). Analisis Kaplan Meier menunjukkan tidak terdapat pengaruh antara toksisitas kemoterapi hematologi fase konsolidasi derajat ringan-sedang vs derajat berat dengan kesintasan selama 3 tahun (64% vs 41% p=0,163, HR 1,941, dan IK 0,764-4.934). Melalui analisis multivariat diperoleh derajat toksisitas merupakan faktor prognostik independen yang memengaruhi terhadap kesintasan (p=0,163, HR 1,941) Kesimpulan. Toksisitas kemoterapi hematologi fase konsolidasi tidak memengaruhi kesintasan 3 tahun pada pasien LLA anak.
Latar belakang. Infeksi merupakan penyebab utama kematian ketiga pada bayi baru lahir setelah komplikasi prematuritas dan asfiksia. Pemberian antibiotik empiris yang sama, baik pada neonatal aterm maupun neonatal preterm, dan penggunaan antibiotik empiris yang tetap dalam 10 tahun terakhir, maka dilakukan penelitian prospektif untuk menganalisis usia gestasi sebagai prediktor keberhasilan terapi antibiotik empiris pada infeksi neonatorum.Tujuan. Menganalisis usia gestasi sebagai prediktor keberhasilan terapi antibiotik empiris pada infeksi neonatorum.Metode. Penelitian ini merupakan penelitian kohort prospektif dengan pendekatan uji prognostik. Penelitian dilakukan di High Care Unit (HCU) Neonatus RSUD Dr. Moewardi Surakarta pada bulan April - Desember 2021. Nama pasien, usia gestasi, jenis kelamin, metode persalinan, berat badan lahir, asupan ASI, hasil kultur darah, jenis antibiotik dan terapi suportif dicatat. Uji chi square dilanjutkan dengan uji multivariat regresi logistik digunakan untuk menganalisis data.Hasil. Dari 146 neonatal infeksi, didapatkan 75 neonatal aterm dan 71 neonatal preterm. Kedua kelompok mendapatkan terapi antibiotik empiris. Analisis multivariat regresi logistik menunjukkan hasil usia gestasi dengan nilai p=0,001, terapi suportif dengan nilai p=0,090 dan kewaspadaan isolasi dengan nilai p=0,010. Usia gestasi aterm didapatkan hasil paling signifikan dengan nilai p=0,001 dan odds rasio 0,289 (IK 95%, 0,137 – 0,612).Kesimpulan. Usia gestasi merupakan prediktor keberhasilan terapi antibiotik empiris pada infeksi neonatorum.
<p class="16"><strong><em>Introduction</em></strong><strong><em>:</em></strong><strong><em> </em></strong><em>Exclusive breast milk is breastfeeding for six months to babies, without providing other foods and drinks. Breastfeeding for up to 6 months is recommended by various health organizations, including the Ministry of Health. In Indonesia, exclusive breastfeeding is still low, even though the benefits of breastfeeding are numerous. Various studies that have been conducted have shown </em><em>different</em><em> results regarding the relationship between the number and sequence of children with breastfeeding practices. This stud</em><em>y </em><em>aimed</em><em> </em><em>to determine the relationship between the number of children and the order of the children with the practice of exclusive breastfeeding in Surakarta</em><em></em></p><p class="16"><strong><em>Methods</em></strong><strong><em>:</em></strong><strong><em> </em></strong><em>This study </em><em>was</em><em> an analytic observational study with a cross-sectional study design. The research sample was determined by random sampling of mothers registered at the Penumping Health Center. The research sample consisted of 50 people who have children aged 1-5 years. Assessment of completeness of breastfeeding was measured using a questionnaire. Data were analyzed using bivariate analysis techniques using chi-square and multivariate logistic regression</em><em>.</em><em></em></p><p class="16"><strong><em>Result</em></strong><strong><em>s and discussions: </em></strong><em>From</em><em> 47</em><em> </em><em>subjects studied with the bivariate analysis technique using the chi square between the number of children and the order of children with exclusive breastfeeding practice, the results were less significant, p = 0.724 and p = 0.401</em><em>.</em><em></em></p><p class="16"><strong><em>Conclusion</em></strong><strong><em>: </em></strong><em>There </em><em>was</em><em> no significant relationship between the number of children and the order of children with the practice of exclusive breastfeeding in Surakarta.</em><em></em></p><p class="18"><strong><em>Keywords</em></strong><strong><em>: </em></strong><strong><em>E</em></strong><strong><em>xc</em></strong><strong><em>lusive breastfeeding, number of children, </em></strong><strong><em>order </em></strong><strong><em>of children</em></strong><strong><em>.</em></strong><strong><em></em></strong></p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.